These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 25834017

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.
    Xue C, Tian G, Chen X, Liu Q, Ma J, Xu S, Li X, Chen H, Cao Y.
    Virus Res; 2015 Jan 02; 195():35-42. PubMed ID: 25312452
    [Abstract] [Full Text] [Related]

  • 5. Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice.
    Huang B, Wang W, Li R, Wang X, Jiang T, Qi X, Gao Y, Tan W, Ruan L.
    Virol J; 2012 Dec 29; 9():322. PubMed ID: 23272943
    [Abstract] [Full Text] [Related]

  • 6. A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.
    Chang H, Huang C, Wu J, Fang F, Zhang W, Wang F, Chen Z.
    Virol J; 2010 Aug 21; 7():197. PubMed ID: 20727202
    [Abstract] [Full Text] [Related]

  • 7. Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2.
    Kim J, Chang J.
    Vaccine; 2024 May 31; 42(15):3505-3513. PubMed ID: 38714444
    [Abstract] [Full Text] [Related]

  • 8. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H, Peng X, Jiao H, Zhao D, Ouyang J.
    Microb Cell Fact; 2015 Aug 05; 14():111. PubMed ID: 26242406
    [Abstract] [Full Text] [Related]

  • 9. Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats.
    Wang W, Huang B, Wang X, Tan W, Ruan L.
    Virol Sin; 2019 Oct 05; 34(5):583-591. PubMed ID: 31240620
    [Abstract] [Full Text] [Related]

  • 10. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M, Tao P, Li J, Zhou S, Guo D, Pan Z.
    J Virol Methods; 2008 Dec 05; 154(1-2):121-7. PubMed ID: 18789973
    [Abstract] [Full Text] [Related]

  • 11. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
    Park KS, Seo YB, Lee JY, Im SJ, Seo SH, Song MS, Choi YK, Sung YC.
    Vaccine; 2011 Jul 26; 29(33):5481-7. PubMed ID: 21664216
    [Abstract] [Full Text] [Related]

  • 12. Progress on adenovirus-vectored universal influenza vaccines.
    Xiang K, Ying G, Yan Z, Shanshan Y, Lei Z, Hongjun L, Maosheng S.
    Hum Vaccin Immunother; 2015 Jul 26; 11(5):1209-22. PubMed ID: 25876176
    [Abstract] [Full Text] [Related]

  • 13. Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge.
    Magini D, Giovani C, Mangiavacchi S, Maccari S, Cecchi R, Ulmer JB, De Gregorio E, Geall AJ, Brazzoli M, Bertholet S.
    PLoS One; 2016 Jul 26; 11(8):e0161193. PubMed ID: 27525409
    [Abstract] [Full Text] [Related]

  • 14. Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant.
    Zheng M, Liu F, Shen Y, Wang S, Xu W, Fang F, Sun B, Xie Z, Chen Z.
    Hum Vaccin Immunother; 2015 Jul 26; 11(2):397-406. PubMed ID: 25607884
    [Abstract] [Full Text] [Related]

  • 15. Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice.
    Asthagiri Arunkumar G, McMahon M, Pavot V, Aramouni M, Ioannou A, Lambe T, Gilbert S, Krammer F.
    Vaccine; 2019 Sep 03; 37(37):5567-5577. PubMed ID: 31399277
    [Abstract] [Full Text] [Related]

  • 16. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC, Lin CY, Tsou YT, Jan JT, Wu SC.
    J Virol; 2015 Jul 03; 89(14):7224-34. PubMed ID: 25948745
    [Abstract] [Full Text] [Related]

  • 17. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB, Buonocore L, Vogel L, Nachbagauer R, Krammer F, Rose JK.
    J Virol; 2015 Mar 03; 89(5):2820-30. PubMed ID: 25540378
    [Abstract] [Full Text] [Related]

  • 18. Analysis of different DNA vaccines for protection of experimental influenza A virus infection.
    Wiesener N, Schütze T, Lapp S, Lehmann M, Jarasch-Althof N, Wutzler P, Henke A.
    Viral Immunol; 2011 Aug 03; 24(4):321-30. PubMed ID: 21830903
    [Abstract] [Full Text] [Related]

  • 19. Influenza virosome/DNA vaccine complex as a new formulation to induce intra-subtypic protection against influenza virus challenge.
    Kheiri MT, Jamali A, Shenagari M, Hashemi H, Sabahi F, Atyabi F, Saghiri R.
    Antiviral Res; 2012 Sep 03; 95(3):229-36. PubMed ID: 22809863
    [Abstract] [Full Text] [Related]

  • 20. Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses.
    Li Z, Gabbard JD, Mooney A, Gao X, Chen Z, Place RJ, Tompkins SM, He B.
    J Virol; 2013 May 03; 87(10):5985-93. PubMed ID: 23514880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.